X Close
TMCnet - World's Largest Communications and Technology Community



SHAREHOLDER ALERT: Investigation on Behalf of Northwest Biotherapeutics, Inc. Investors Announced by Law Offices of Howard G. Smith
[June 19, 2014]

SHAREHOLDER ALERT: Investigation on Behalf of Northwest Biotherapeutics, Inc. Investors Announced by Law Offices of Howard G. Smith

BENSALEM, Pa. --(Business Wire)--

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Northwest Biotherapeutics, Inc. ("Northwest Biotherapeutics" or the "Company") (NASDAQ:NWBO). The investigation concerns possible violations of federal securities laws and focuses on certain statements issued by Northwest Biotherapeutics concerning the Company's operations and prospects.

Northwest Biotherapeutics is a biotechnology company engaged in the discovery and development of immunotherapy products to treat cancers in the United States and internationally. The Company is involved in th development of DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. The investigation is related to an article published June 19, 2014, by TheStreet.com, alleging that the MD Anderson Cancer Center "issued a stern rebuke to Northwest Biotherapeutics for making promotional, unjustified claims about results from an ongoing clinical trial of an experimental cancer vaccine known as DCVax-Direct." The article further alleges that the vice president of clinical research at the MD Anderson Cancer Center stated that claims in certain of the Company's press releases concerning the DCVax-Direct clinical trials are preliminary and unconfirmed. Following this news, the price of Northwest Biotherapeutics shares dropped nearly 20 percent in intraday trading on June 19, 2014.

If you purchased Northwest Biotherapeutics securities, if you have information or would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

[ Back To TMCnet.com's Homepage ]

Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.


© 2015 Technology Marketing Corporation. All rights reserved | Privacy Policy